Scott Bizily, Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 500 shares at $16.33 ($8K) on 2024-09-16, disclosed to the SEC on 2024-09-18.
Scheduled sale ($8k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FDMT | SELL | 2026-08-17 | $40K | — | Filing → |
| FDMT | SELL | 2026-07-02 | $92K | — | Filing → |
| FDMT | SELL | 2026-06-25 | $118K | — | Filing → |